Sandeep Bansal, MD
Clinical Cardiac Electrophysiology · Lancaster, PANPI 1861586133
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 40.5% of the total.
Across 366 payments — averaging $274.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$41K
- Merit Medical Systems Inc$18K
- Biosense Webster, Inc.$14K
- Abbott$13K
- Medical Device Business Services, Inc.$5K
- Boston Scientific$4K
- plus $6K from 15 others
Across 72 payments — averaging $3505.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$132K
- Abbott$109K
- Galvanize Therapeutics, Inc$11K
- Impulse Dynamics (USA) Inc.$890
What the payments were for
- Consulting fees$40,69841%
- Speaking & faculty fees$23,82024%
- Travel & lodging$23,42723%
- Food & beverage$12,42612%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 128 | $40,693 |
| Merit Medical Systems Inc | 14 | $17,940 |
| Biosense Webster, Inc. | 70 | $14,426 |
| Abbott | 59 | $12,987 |
| Medical Device Business Services, Inc. | 5 | $4,537 |
| Boston Scientific | 61 | $3,933 |
| Impulse Dynamics (USA) Inc. | 1 | $3,000 |
| Regeneron Healthcare Solutions, Inc. | 8 | $1,744 |
| AstraZeneca | 5 | $440 |
| Actelion Pharmaceuticals US, Inc. | 1 | $138 |
| Viatris Specialty LLC | 1 | $125 |
| Regeneron | 2 | $102 |
| Biotronik Inc. | 1 | $97 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Verona Pharma, Inc. | 2 | $48 |
| GSK | 1 | $48 |
| Abiomed | 2 | $38 |
| Novo Nordisk | 1 | $21 |
| Pulmonx Corporation | 1 | $20 |
| Teleflex LLC | 1 | $18 |
| Electromed, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$14,677
- SelectSecure$7,192
- Merlin Connectivity and Remote$4,725
- Micra$2,869
- EVERA MRI XT DR SURESCAN$1,829
- DUPIXENT$1,432
- Allure CRT Pacemaker$1,394
- Agilis NxT EP Introducer$1,313
- AVEIR$1,072
- TENDRIL$1,050
- Watchman$981
- AURORA EV-ICD MRI SURESCAN$819
- Carto 3 System$678
- BREZTRI$351
- Confirm Rx$325
- Assurity Pacemaker$292
- AZURE XT DR MRI SURESCAN$280
- WATCHMAN FLX$254
- QUADRA ASSURA$223
- Allure Quadra RF CRT Pacemaker$203
How this compares
$100,456 in reported general payments places this provider in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $103,814 |
| XareltoRivaroxaban | 118 | $78,875 |
| MultaqDronedarone Hcl | 11 | $8,053 |
| Metoprolol Succinate | 111 | $1,329 |
| Amiodarone Hcl | 59 | $914 |
| SotalolSotalol Hcl | 62 | $728 |
| Flecainide Acetate | 14 | $625 |
| Pantoprazole Sodium | 35 | $187 |
| Carvedilol | 22 | $76 |
| Levothyroxine Sodium | 14 | $65 |
| Metoprolol Tartrate | 25 | $47 |
| Furosemide | 23 | $47 |
| Atorvastatin Calcium | 14 | $42 |
| Spironolactone | 14 | $27 |
| Hydrochlorothiazide | 22 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $85 | $8,05311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Lancaster
- Seth WorleyLancaster$3.7M
- Matthew BernabeiLancaster$52K
- Choudhary ChahalLancaster$52K
- Jeffrey ArklesLancaster$48K
- John ChenaridesPittsburgh$750K
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pugazhendhi VijayaramanWilkes Barre$594K
- Pasquale SantangeliPhiladelphia$581K
- Joshua SilversteinPittsburgh$557K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.